← Leaderboards
Clarence Buddy Creech
Vanderbilt University Medical Center
$64,037,457
Attributed
$65,258,141
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $18.6M · FY2008–25$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,258,141 · 5
By mechanism
UM1$50,653,575 · 1
N01$11,681,924 · 1
R01$2,441,369 · 1
K23$475,273 · 1
R13$6,000 · 1
Top collaborators
- George Y Liu3 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Nafiu Hussain$294,915
- Michael Rutledge Debaun$40,846,229
- Mustapha Shu'aibu Hikima$220,757
- Shehu Umar Abdullahi$872,336
- Jennifer Nixon$2,776,885
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignConduct Clinical TrialsVaccinesEvaluationCommunicable DiseasesProgramsInfectionNamed GroupChildContractsResourcesClinical ResearchTrainingSiteResearch StudyCombatImmune ResponseClinical TrialsAdultUniversitiesPathogenesisResearch PersonnelChildhoodFaculty
Grant awards (57)
Vanderbilt Vaccine and Treatment Evaluation Unit$1,001,368
UM1 · FY2025 · AI · contact PI
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights$808,814
R01 · FY2025 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit$1,427,717
UM1 · FY2024 · AI · contact PI
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights$813,730
R01 · FY2024 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit$1,972,714
UM1 · FY2023 · AI · contact PI
Interrogating human anti-staphylococcal antibody responses for S. aureus vaccine insights$818,825
R01 · FY2023 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit$650,727
UM1 · FY2023 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$13,319,092
UM1 · FY2022 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$2,059,956
UM1 · FY2022 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$1,543,286
UM1 · FY2022 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$657,610
UM1 · FY2022 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$592,422
UM1 · FY2022 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$303,464
UM1 · FY2022 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays$121,453
N01 · FY2022 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit - KidCOVE$5,245,366
UM1 · FY2021 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$4,613,138
UM1 · FY2021 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit - DMID 21-0012$1,046,814
UM1 · FY2021 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$665,119
UM1 · FY2021 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit - DMID 21-0004$658,548
UM1 · FY2021 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$614,901
UM1 · FY2021 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$192,338
UM1 · FY2021 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays$120,476
N01 · FY2021 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$12,509,936
UM1 · FY2020 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$842,642
UM1 · FY2020 · AI · contact PI
Vanderbilt Vaccine and Treatment Evaluation Unit$736,417
UM1 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays$118,780
N01 · FY2020 · AI · contact PI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Trial for Influenza Vaccine$875,247
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays$305,327
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Concept Development$197,284
N01 · FY2019 · AI · contact PI
Vaccine Treatment and Evaluation Unit: Phase I Influenza Vaccine Clinical Trial$180,390
N01 · FY2019 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT:CONCEPT AND PROTOCOL DEVELOPMENT$1,174,469
N01 · FY2018 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNIT: POPULATION PHARMACOKINETIC ANALYSES$633,396
N01 · FY2018 · AI · contact PI
VTEUs: Vaccines for Bordetella$524,595
N01 · FY2018 · AI · contact PI
Vaccine and Treatment Evaluation Units: Concept Development$296,952
N01 · FY2018 · AI · contact PI
VTEU: POPULATION PHARMACOKINETIC ANALYSES$248,947
N01 · FY2018 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: CLINICAL OPERATIONS SUPPORT$189,411
N01 · FY2018 · AI · contact PI
Vaccine Treatment and Evaluation Units: A Phase IV Trial to Evaluate Antimicrobial Therapy for Community Acquired Pneumonia in Children$2,440,693
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT:CONCEPT AND PROTOCOL DEVELOPMENT$768,693
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: PHASE I/II THERAPEUTIC TRIAL FOR CLOSTRIDIUM DIFFICILE$485,489
N01 · FY2017 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNIT: POPULATION PHARMACOKINETIC ANALYSES$310,219
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: CLINICAL OPERATIONS SUPPORT$276,846
N01 · FY2017 · AI · contact PI
VTEU: POPULATION PHARMACOKINETIC ANALYSES$131,810
N01 · FY2017 · AI · contact PI
Vaccine Treatment and Evaluation Unit: Phase I Influenza Vaccine Clinical Trial$119,945
N01 · FY2017 · AI · contact PI
St. Jude/PIDS Pediatric Infectious Diseases Research Conference$6,000
R13 · FY2017 · AI · contact PI
VTEU: Phase I Influenza Vaccine Clinical Trial$560,492
N01 · FY2016 · AI · contact PI
VTEU: A Phase IV Trial to Evaluate Antimicrobial Therapy of Community Acquired Pneumonia in Children$452,589
N01 · FY2016 · AI · contact PI
VTEU: STI Diagnostic Studies$249,089
N01 · FY2016 · AI · contact PI
Vaccine and Treatment Evaluation Unit$114,190
N01 · FY2016 · AI · contact PI
VTEU: POPULATION PHARMACOKINETIC ANALYSES$89,913
N01 · FY2016 · AI · contact PI
Vaccine and Treatment Evaluation Unit$280,264
N01 · FY2015 · AI · contact PI
Assay Work for Influenza Vaccines - VTEU$236,233
N01 · FY2015 · AI · contact PI
A Phase IV Trial to Evaluate Antimicrobial Therapy of Community Acquired Pneumonia in Children - VTEU$178,732
N01 · FY2015 · AI · contact PI
A longitudinal Study of CA-MRSA Nasal Colonization in College Sports Participants$125,091
K23 · FY2010 · AI · contact PI
A longitudinal Study of CA-MRSA Nasal Colonization in College Sports Participants$50,000
K23 · FY2010 · AI · contact PI
A longitudinal Study of CA-MRSA Nasal Colonization in College Sports Participants$125,091
K23 · FY2009 · AI · contact PI
A longitudinal Study of CA-MRSA Nasal Colonization in College Sports Participants$50,000
K23 · FY2009 · AI · contact PI
A longitudinal Study of CA-MRSA Nasal Colonization in College Sports Participants$125,091
K23 · FY2008 · AI · contact PI